The Journal of Hip Surgery 2020; 04(02): 045-059
DOI: 10.1055/s-0040-1708537
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Risk Factors for Blood Transfusion in Revision Total Hip Arthroplasty for Mechanical Failure

Ryan Lee
1   The George Washington University School of Medicine and Health Sciences, The George Washington University in Washington, Washington, District of Columbia
,
Danny Lee
1   The George Washington University School of Medicine and Health Sciences, The George Washington University in Washington, Washington, District of Columbia
,
Safa Fassihi
2   Department of Orthopaedic Surgery, The George Washington University Hospital, Washington, District of Columbia
,
Zachary Zeller
1   The George Washington University School of Medicine and Health Sciences, The George Washington University in Washington, Washington, District of Columbia
,
Seth Stake
2   Department of Orthopaedic Surgery, The George Washington University Hospital, Washington, District of Columbia
,
Jason Kappa
2   Department of Orthopaedic Surgery, The George Washington University Hospital, Washington, District of Columbia
,
Michael Webber
2   Department of Orthopaedic Surgery, The George Washington University Hospital, Washington, District of Columbia
,
Savyasachi C. Thakkar
3   Department of Orthopaedic Surgery, MedStar Georgetown Orthopaedic Institute, Hospital Center in Washington, Washington, District of Columbia
,
Rajeev Pandarinath
2   Department of Orthopaedic Surgery, The George Washington University Hospital, Washington, District of Columbia
› Author Affiliations
Further Information

Publication History

09 June 2019

04 February 2020

Publication Date:
08 April 2020 (online)

Abstract

Revision total hip arthroplasty (rTHA) is associated with significant intraoperative blood loss requiring transfusion. Given that blood transfusions increase the risk of numerous complications, efforts should be made to determine which patients are at high risk of transfusion and optimize them appropriately. This study aimed to identify independent risk factors associated with blood transfusion in patients undergoing rTHA for mechanical failure. A multi-institutional surgical registry was queried for all patients who underwent rTHA for mechanical failure from 2005 to 2016. Patients were divided into transfused and nontransfused cohorts and underwent univariate analysis for differences in demographic features, preoperative comorbidities, and operative variables. Multivariate regression models were generated to elucidate independent risk factors associated with perioperative blood transfusions. A total of 8,469 rTHA patients met inclusion and exclusion criteria, of which 1,863 (22.0%) received blood transfusions within 72 hours postoperatively. On multivariate logistic regression analysis, age ≥ 65 years (odds ratio [OR] 1.313; p < 0.001), female gender (OR 1.465; p < 0.001), insulin-dependent diabetes mellitus (OR 1.503; p = 0.003), chronic obstructive pulmonary disease (COPD; OR 1.307; p = 0.030), hypertension (OR 1.359; p < 0.001), hematologic disorders (OR 1.565; p < 0.001), preoperative blood transfusions (OR 3.851; p < 0.001), systemic sepsis (OR 2.277; p = 0.003), functional dependence (OR 1.416; p = 0.003), open wounds/wound infections (OR 2.878; p < 0.001), and operations lasting at least 175 minutes (OR 4.841; p < 0.001) were all significant independent risk factors for blood transfusions. Obesity (body mass index [BMI] ≥ 30 kg/m2; OR 0.818; p = 0.001), smoking history (OR 0.800; p = 0.014), and isolated acetabular component revision (OR 0.730; p < 0.001) were associated with a decreased risk of blood transfusion. Older age, female gender, lower BMI, absence of smoking history, functional dependence, insulin-dependent diabetes mellitus, hypertension, revision of the femoral component, preoperative transfusion, hematologic disorders, sepsis, open wounds/wound infections, COPD, and longer operative time were all independent risk factors for blood transfusions in rTHA performed for mechanical failure. By identifying these risk factors, clinicians can identify and optimize high-risk patients to minimize blood transfusion requirements, thereby reducing the risk of transfusion-associated complications in this patient population.

 
  • References

  • 1 Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study. Transfusion 2010; 50 (10) 2117-2124
  • 2 Rosencher N, Kerkkamp HE, Macheras G. , et al; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43 (04) 459-469
  • 3 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 4 Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005; 45 (Suppl. 02) 33S-39S , discussion 39S–40S
  • 5 Bloomfield MR, Patterson RW, Froimson MI. Complications of anticoagulation for thromboembolism in early postoperative total joint arthroplasty. Am J Orthop 2011; 40 (08) E148-E151
  • 6 Clifford L, Jia Q, Yadav H. , et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 2015; 122 (01) 21-28
  • 7 Pedersen AB, Mehnert F, Overgaard S, Johnsen SP. Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009; 10: 167
  • 8 Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 2005; 45 (01) 103-110
  • 9 Patil S, Garbuz DS, Greidanus NV, Masri BA, Duncan CP. Quality of life outcomes in revision vs primary total hip arthroplasty: a prospective cohort study. J Arthroplasty 2008; 23 (04) 550-553
  • 10 Kimball CC, Nichols CI, Vose JG. Blood transfusion trends in primary and revision total joint arthroplasty: recent declines are not shared equally. J Am Acad Orthop Surg 2019; 27 (20) e920-e927
  • 11 Sculco TP. Global blood management in orthopaedic surgery. Clin Orthop Relat Res 1998; (357) 43-49
  • 12 Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 2002; 10 (06) 393-400
  • 13 Schwartz BE, Piponov HI, Helder CW, Mayers WF, Gonzalez MH. Revision total hip arthroplasty in the United States: national trends and in-hospital outcomes. Int Orthop 2016; 40 (09) 1793-1802
  • 14 Bozic KJ, Kamath AF, Ong K. , et al. Comparative epidemiology of revision arthroplasty: failed THA poses greater clinical and economic burdens than failed TKA. Clin Orthop Relat Res 2015; 473 (06) 2131-2138
  • 15 National Surgical Quality Improvement Program. User guide for 2012 ACS NSQIP participant use data file. Chicago, IL: American College of Surgeons; 2013. . Available at: https://www.facs.org/~/media/files/quality%20programs/nsqip/ug12.ashx . Accessed September 17, 2018
  • 16 Mahadevan D, Challand C, Keenan J. Revision total hip replacement: predictors of blood loss, transfusion requirements, and length of hospitalisation. J Orthop Traumatol 2010; 11 (03) 159-165
  • 17 Corbett KL, Losina E, Nti AA, Prokopetz JJZ, Katz JN. Population-based rates of revision of primary total hip arthroplasty: a systematic review. PLoS One 2010; 5 (10) e13520
  • 18 Karachalios T, Komnos G, Koutalos A. Total hip arthroplasty: survival and modes of failure. EFORT Open Rev 2018; 3 (05) 232-239
  • 19 Swedish Hip Arthroplasty Register Annual Report 2014. Available at: https://registercentrum.blob.core.windows.net/shpr/r/Annual-report-2014-BJv-q8pil.pdf . Accessed March 7, 2018
  • 20 Fender D, van der Meulen JH, Gregg PJ. Relationship between outcome and annual surgical experience for the Charnley total hip replacement. Results from a regional hip register. J Bone Joint Surg Br 2003; 85 (02) 187-190
  • 21 Röder C, Bach B, Berry DJ, Eggli S, Langenhahn R, Busato A. Obesity, age, sex, diagnosis, and fixation mode differently affect early cup failure in total hip arthroplasty: a matched case-control study of 4420 patients. J Bone Joint Surg Am 2010; 92 (10) 1954-1963
  • 22 Sarpong NO, Grosso MJ, Lakra A, Held MB, Herndon CL, Cooper HJ. Hemiarthroplasty conversion: a comparison to primary and revision total hip arthroplasty. J Arthroplasty 2019; 34 (06) 1168-1173
  • 23 Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am 2014; 96 (23) 1945-1951
  • 24 Song K, Pan P, Yao Y, Jiang T, Jiang Q. The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty. J Orthop Surg Res 2019; 14 (01) 273
  • 25 Kesler KK, Brown TS, Martin JR, Springer BD, Otero J. Risk factors for blood transfusion after primary total hip arthroplasty. Reconstr Rev 2019; 9: 49-53
  • 26 Barr PJ, Donnelly M, Cardwell C. , et al. Drivers of transfusion decision making and quality of the evidence in orthopedic surgery: a systematic review of the literature. Transfus Med Rev 2011; 25 (04) 304-16.e1 , 6
  • 27 Feagan BG, Wong CJ, Lau CY, Wheeler SL, Sue-A-Quan G, Kirkley A. Transfusion practice in elective orthopaedic surgery. Transfus Med 2001; 11 (02) 87-95
  • 28 Burnett RA, Bedard NA, DeMik DE, Gao Y, Liu SS, Callaghan JJ. Recent trends in blood utilization after revision hip and knee arthroplasty. J Arthroplasty 2017; 32 (12) 3693-3697
  • 29 Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty 2013; 28 (Suppl. 08) 34-37
  • 30 Murphy WG. The sex difference in haemoglobin levels in adults—mechanisms, causes, and consequences. Blood Rev 2014; 28 (02) 41-47
  • 31 Frisch N, Wessell NM, Charters M. , et al. Effect of body mass index on blood transfusion in total hip and knee arthroplasty. Orthopedics 2016; 39 (05) e844-e849
  • 32 Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res 2015; 10: 48
  • 33 Akinleye SD, Garofolo G, Culbertson MD, Homel P, Erez O. The role of BMI in hip fracture surgery. Geriatr Orthop Surg Rehabil 2018; 9: 2151458517747414
  • 34 Prasad N, Padmanabhan V, Mullaji A. Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop 2007; 31 (01) 39-44
  • 35 Hrnack SA, Skeen N, Xu T, Rosenstein AD. Correlation of body mass index and blood loss during total knee and total hip arthroplasty. Am J Orthop 2012; 41 (10) 467-471
  • 36 Bowditch MG, Villar RN. Do obese patients bleed more? A prospective study of blood loss at total hip replacement. Ann R Coll Surg Engl 1999; 81 (03) 198-200
  • 37 Werner BC, Higgins MD, Pehlivan HC, Carothers JT, Browne JA. Super obesity is an independent risk factor for complications after primary total hip arthroplasty. J Arthroplasty 2017; 32 (02) 402-406
  • 38 Khan LA, Cowie JG, Ballantyne JA, Brenkel IJ. The complication rate and medium-term functional outcome after total hip replacement in smokers. Hip Int 2009; 19 (01) 47-51
  • 39 Kandil A, Griffin JW, Novicoff WM, Brockmeier SF. Blood transfusion after total shoulder arthroplasty: which patients are at high risk?. Int J Shoulder Surg 2016; 10 (02) 72-77
  • 40 Grosflam JM, Wright EA, Cleary PD, Katz JN. Predictors of blood loss during total hip replacement surgery. Arthritis Care Res 1995; 8 (03) 167-173
  • 41 McCunniff PT, Young ES, Ahmadinia K, Ahn UM, Ahn NU. Smoking is associated with increased blood loss and transfusion use after lumbar spinal surgery. Clin Orthop Relat Res 2016; 474 (04) 1019-1025
  • 42 Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA 1990; 264 (12) 1556-1559
  • 43 Subratty AH, Mooradun A, Jowaheer V. [TAME]-esterase--a new cardiovascular risk factor in smokers. Indian J Exp Biol 2000; 38 (06) 610-612
  • 44 Du Plooy JN, Buys A, Duim W, Pretorius E. Comparison of platelet ultrastructure and elastic properties in thrombo-embolic ischemic stroke and smoking using atomic force and scanning electron microscopy. PLoS One 2013; 8 (07) e69774
  • 45 Padmavathi P, Reddy VD, Maturu P, Varadacharyulu N. Smoking-induced alterations in platelet membrane fluidity and Na(+)/K(+)-ATPase activity in chronic cigarette smokers. J Atheroscler Thromb 2010; 17 (06) 619-627
  • 46 Pretorius E. Ultrastructural changes in platelet membranes due to cigarette smoking. Ultrastruct Pathol 2012; 36 (04) 239-243
  • 47 Bedard NA, Dowdle SB, Owens JM, Duchman KR, Gao Y, Callaghan JJ. What is the impact of smoking on revision total hip arthroplasty?. J Arthroplasty 2018; 33 (7S): S182-S185
  • 48 Curtis GL, Hammad A, Anis HK, Higuera CA, Little BE, Darwiche HF. Dependent functional status is a risk factor for perioperative and postoperative complications after total hip arthroplasty. J Arthroplasty 2019; 34 (7S): S348-S351
  • 49 Klasan A, Dworschak P, Heyse TJ. , et al. Transfusions increase complications and infections after hip and knee arthroplasty: an analysis of 2760 cases. Technol Health Care 2018; 26 (05) 825-832
  • 50 Browne JA, Cook C, Pietrobon R, Bethel MA, Richardson WJ. Diabetes and early postoperative outcomes following lumbar fusion. Spine 2007; 32 (20) 2214-2219
  • 51 Berenholtz SM, Pronovost PJ, Mullany D. , et al. Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000. Transfusion 2002; 42 (02) 183-189
  • 52 Schipper ON, Jiang JJ, Chen L, Koh J, Toolan BC. Effect of diabetes mellitus on perioperative complications and hospital outcomes after ankle arthrodesis and total ankle arthroplasty. Foot Ankle Int 2015; 36 (03) 258-267
  • 53 Toor AS, Jiang JJ, Shi LL, Koh JL. Comparison of perioperative complications after total elbow arthroplasty in patients with and without diabetes. J Shoulder Elbow Surg 2014; 23 (11) 1599-1606
  • 54 Simpson JM, Silveri CP, Balderston RA, Simeone FA, An HS. The results of operations on the lumbar spine in patients who have diabetes mellitus. J Bone Joint Surg Am 1993; 75 (12) 1823-1829
  • 55 Glassman SD, Alegre G, Carreon L, Dimar JR, Johnson JR. Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitus. Spine J 2003; 3 (06) 496-501
  • 56 Gu A, Wei C, Robinson HN. , et al. Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty. J Knee Surg 2020; 33 (03) 228-234
  • 57 Sobel BE, Schneider DJ. Platelet function, coagulopathy, and impaired fibrinolysis in diabetes. Cardiol Clin 2004; 22 (04) 511-526
  • 58 Legosz P, Platek AE, Kotkowski M. , et al. Clinical characteristics of hypertensive patients undergoing total hip or knee replacement. Arterial Hypertension 2017; 21: 29-33
  • 59 Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am 2004; 86 (01) 57-61
  • 60 Jiang J, Yue Y, Li B, Zhou R. Deliberate hypotension for orthopaedic surgery. Cochrane Database Syst Rev 2017; 2017: CD012096
  • 61 Niemi TT, Pitkänen M, Syrjälä M, Rosenberg PH. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand 2000; 44 (04) 457-464
  • 62 Manjuladevi M, Vasudeva Upadhyaya K. Perioperative blood management. Indian J Anaesth 2014; 58 (05) 573-580
  • 63 Roche M, Law TY, Rosas S. , et al. Transfusion requirements following total knee arthroplasty in patients with preexisting blood dyscrasia. Surg Technol Int 2017; 30: 435-440
  • 64 Jans Ø, Jørgensen C, Kehlet H, Johansson PI. ; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2014; 54 (03) 717-726
  • 65 Ryan SP, Klement MR, Green CL, Blizzard DJ, Wellman SS, Seyler TM. Preoperative hemoglobin predicts postoperative transfusion despite antifibrinolytics during total knee arthroplasty. Orthopedics 2019; 42 (02) 103-109
  • 66 Murthy T. Blood transfusion practices in sepsis. Indian J Anaesth 2014; 58 (05) 643-646
  • 67 Carson JL, Guyatt G, Heddle NM. , et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 2016; 316 (19) 2025-2035
  • 68 Malcherczyk D, Klasan A, Ebbinghaus A. , et al. Factors affecting blood loss and blood transfusion in patients with proximal humeral fractures. J Shoulder Elbow Surg 2019; 28 (06) e165-e174
  • 69 Ewing MA, Huntley SR, Baker DK. , et al. Blood transfusion during total ankle arthroplasty is associated with increased in-hospital complications and costs. Foot Ankle Spec 2019; 12 (02) 115-121
  • 70 Sarkar M, Rajta PN, Khatana J. Anemia in chronic obstructive pulmonary disease: prevalence, pathogenesis, and potential impact. Lung India 2015; 32 (02) 142-151
  • 71 Ross D, Erkocak O, Rasouli MR, Parvizi J. Operative time directly correlates with blood loss and need for blood transfusion in total joint arthroplasty. Arch Bone Jt Surg 2019; 7 (03) 229-234
  • 72 Goel R, Chappidi MR, Patel EU. , et al. Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014. JAMA 2018; 319 (08) 825-827
  • 73 Haynes JA, Stambough JB, Sassoon AA, Johnson SR, Clohisy JC, Nunley RM. Contemporary surgical indications and referral trends in revision total hip arthroplasty: a 10-year review. J Arthroplasty 2016; 31 (03) 622-625
  • 74 Singh J, Politis A, Loucks L, Hedden DR, Bohm ER. Trends in revision hip and knee arthroplasty observations after implementation of a regional joint replacement registry. Can J Surg 2016; 59 (05) 304-310
  • 75 American College of Surgeons—National Surgical Quality Improvement Program. ACS-NSQIP Operations Manual: Variables and Definitions 2015 PUF User Guide. October, 2016. Available at: https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_user_guide_2015.ashx . Accessed December 19, 2019
  • 76 Transition from ICD-9-CM to ICD-10. Baltimore, MD: U.S. Centers for Medicare and Medicaid Services; 2019. . Available at: https://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes . Accessed December 29, 2019
  • 77 Castano-Betancourt MC, Fruschein Annichino R, de Azevedo E. , et al. Identification of high-risk groups for complications after arthroplasty: predictive value of patient's related risk factors. J Orthop Surg Res 2018; 13: 328
  • 78 Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am 2013; 95 (24) 2177-2184
  • 79 Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 2007; 22 (05) 651-656
  • 80 Shahi A, Tan TL, Chen AF, Maltenfort MG, Parvizi J. In-hospital mortality in patients with periprosthetic joint infection. J Arthroplasty 2017; 32 (03) 948-952.e1
  • 81 Gundtoft PH, Pedersen AB, Varnum C, Overgaard S. Increased mortality after prosthetic joint infection in primary THA. Clin Orthop Relat Res 2017; 475 (11) 2623-2631